Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma - Yeh, Chun-Nan; Cheng, Chi-Tung; Huang, Shih-Chiang; Chen, Ming Huang; Tsai, Chun-Yi; Chen, Yen-Yang; Ma, Ming-Chun; Liu, Chien-Ting; Chen, Tsung-Wen; Yeh, Ta-Sen; Chu, Yin-Yin; Chiang, Kun-Chun; et al. (OncoTargets and therapy, 2015)
Keywords: Anemia; Antigens; Cancer therapies; Cell adhesion & migration; Chemotherapy; DNA methylation; Fibroblasts; Gene expression; Glycoproteins; Growth factors; Health aspects; Hematology; Hepatectomy; Immunohistochemistry; Liver; Medical prognosis; Metastasis; Mortality; Original Research; Pancreatic cancer; Patients; Proteins; Radiation therapy; Surgery; Survival analysis; Tomography; Denmark; United States--US; Taiwan; mass-forming cholangiocarcinoma; SPARC; predicting factors; prognosis